Free Trial

Ginkgo Bioworks (DNA) Competitors

Ginkgo Bioworks logo
$9.76 +0.16 (+1.64%)
Closing price 03:59 PM Eastern
Extended Trading
$9.74 -0.02 (-0.17%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DNA vs. TWST, AMRX, CPRX, BHC, OGN, MIRM, XENE, IBRX, GMTX, and ARWR

Should you be buying Ginkgo Bioworks stock or one of its competitors? The main competitors of Ginkgo Bioworks include Twist Bioscience (TWST), Amneal Pharmaceuticals (AMRX), Catalyst Pharmaceuticals (CPRX), Bausch Health Cos (BHC), Organon & Co. (OGN), Mirum Pharmaceuticals (MIRM), Xenon Pharmaceuticals (XENE), ImmunityBio (IBRX), Gemini Therapeutics (GMTX), and Arrowhead Pharmaceuticals (ARWR). These companies are all part of the "pharmaceutical products" industry.

Ginkgo Bioworks vs. Its Competitors

Twist Bioscience (NASDAQ:TWST) and Ginkgo Bioworks (NYSE:DNA) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

78.6% of Ginkgo Bioworks shares are held by institutional investors. 3.0% of Twist Bioscience shares are held by insiders. Comparatively, 9.7% of Ginkgo Bioworks shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Twist Bioscience presently has a consensus target price of $50.40, indicating a potential upside of 40.59%. Ginkgo Bioworks has a consensus target price of $8.50, indicating a potential downside of 12.88%. Given Twist Bioscience's stronger consensus rating and higher probable upside, equities research analysts clearly believe Twist Bioscience is more favorable than Ginkgo Bioworks.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Twist Bioscience
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.70
Ginkgo Bioworks
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Twist Bioscience has a net margin of -54.98% compared to Ginkgo Bioworks' net margin of -198.84%. Twist Bioscience's return on equity of -33.48% beat Ginkgo Bioworks' return on equity.

Company Net Margins Return on Equity Return on Assets
Twist Bioscience-54.98% -33.48% -25.34%
Ginkgo Bioworks -198.84%-52.35%-27.14%

Twist Bioscience has higher revenue and earnings than Ginkgo Bioworks. Twist Bioscience is trading at a lower price-to-earnings ratio than Ginkgo Bioworks, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Twist Bioscience$312.97M6.86-$208.73M-$3.25-11.03
Ginkgo Bioworks$237.42M2.41-$547.03M-$9.16-1.07

Twist Bioscience has a beta of 2.41, suggesting that its share price is 141% more volatile than the S&P 500. Comparatively, Ginkgo Bioworks has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500.

In the previous week, Twist Bioscience had 5 more articles in the media than Ginkgo Bioworks. MarketBeat recorded 7 mentions for Twist Bioscience and 2 mentions for Ginkgo Bioworks. Twist Bioscience's average media sentiment score of 0.31 beat Ginkgo Bioworks' score of 0.15 indicating that Twist Bioscience is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Twist Bioscience
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ginkgo Bioworks
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Twist Bioscience beats Ginkgo Bioworks on 13 of the 16 factors compared between the two stocks.

Get Ginkgo Bioworks News Delivered to You Automatically

Sign up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DNA vs. The Competition

MetricGinkgo BioworksMED IndustryMedical SectorNYSE Exchange
Market Cap$571.10M$2.93B$5.50B$20.79B
Dividend YieldN/A2.46%4.25%3.67%
P/E Ratio-1.0720.3128.1027.50
Price / Sales2.41261.57402.2885.54
Price / CashN/A42.3835.5321.88
Price / Book0.747.838.264.66
Net Income-$547.03M-$55.11M$3.24B$994.58M
7 Day Performance-9.43%2.18%0.50%-0.69%
1 Month Performance13.65%12.98%7.99%5.41%
1 Year PerformanceN/A1.98%28.68%9.18%

Ginkgo Bioworks Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DNA
Ginkgo Bioworks
0.7732 of 5 stars
$9.76
+1.6%
$8.50
-12.9%
N/A$571.10M$237.42M-1.07640News Coverage
TWST
Twist Bioscience
4.2717 of 5 stars
$35.59
-6.8%
$50.40
+41.6%
-37.5%$2.13B$312.97M-10.95990
AMRX
Amneal Pharmaceuticals
2.8574 of 5 stars
$8.41
-0.1%
$11.60
+37.9%
+8.7%$2.64B$2.79B-210.208,100
CPRX
Catalyst Pharmaceuticals
4.8945 of 5 stars
$20.95
-2.4%
$32.83
+56.7%
+24.7%$2.56B$491.73M13.3480Positive News
BHC
Bausch Health Cos
3.7148 of 5 stars
$6.88
-2.5%
$7.42
+7.8%
-14.7%$2.55B$9.63B-62.5520,700
OGN
Organon & Co.
4.8563 of 5 stars
$9.74
-2.2%
$18.00
+84.8%
-53.7%$2.53B$6.29B3.384,000
MIRM
Mirum Pharmaceuticals
3.118 of 5 stars
$50.47
+0.3%
$65.50
+29.8%
+32.0%$2.50B$379.25M-31.35140
XENE
Xenon Pharmaceuticals
3.4725 of 5 stars
$31.83
-4.3%
$54.82
+72.2%
-26.4%$2.44B$9.43M-9.85210Positive News
IBRX
ImmunityBio
2.1965 of 5 stars
$2.72
flat
$12.25
+350.4%
-57.0%$2.40B$14.74M-4.69590
GMTX
Gemini Therapeutics
N/A$54.75
+3.0%
N/A+14.3%$2.37BN/A-54.7530
ARWR
Arrowhead Pharmaceuticals
3.7554 of 5 stars
$16.84
+0.3%
$43.71
+159.6%
-38.1%$2.33B$3.55M-12.03400News Coverage

Related Companies and Tools


This page (NYSE:DNA) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners